Problem statement: Answer the multiple-choice question.
Question: Which compound has a -31.707% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a. COc1cccc(N=Cc2c(O)n(Cc3ccco3)c(=O)[nH]c2=O)c1
b. c1ccc(-c2cn3c(n2)-c2ccccc2C3)cc1
c. CCC(C)(C)n1nnnc1C(c1ccc2ncccc2c1)N1CCN(c2ccc(O)cc2)CC1
d. COc1ccc(-c2nnn(CC(=O)NCc3ccc4c(c3)OCO4)n2)cc1OC
e. CC(C)(C)C1CCc2onc(C(=O)Nc3cccc(O)c3)c2C1
Answer: c. CCC(C)(C)n1nnnc1C(c1ccc2ncccc2c1)N1CCN(c2ccc(O)cc2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)(C)n1nnnc1C(c1ccc2ncccc2c1)N1CCN(c2ccc(O)cc2)CC1
CCC(C)(C)n1nnnc1C(c1ccc2ncccc2c1)N1CCN(c2ccc(O)cc2)CC1
4-[4-[[1-(2-methylbutan-2-yl)tetrazol-5-yl]-quinolin-6-ylmethyl]piperazin-1-yl]phenol